Rubella and pregnancy: Diagnosis, management and outcomes

Prenatal Diagnosis

Volumn 34, Issue 13, 2014, Pages 1246-1253

  Bouthry, Elise ^a   Picone, Olivier ^b,c   Hamdi, Ghada ^b   Grangeot Keros, Liliane ^a   Ayoubi, Jean Marc ^b   Vauloup Fellous, Christelle ^a  

^a UNIVERSITÉ PARIS SACLAY   (France)

^b FOCH HOSPITAL   (France)

^c LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

Author keywords

[No Author keywords available]

Indexed keywords

RUBELLA VACCINE;

FEMALE; HUMAN; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; RUBELLA; RUBELLA SYNDROME, CONGENITAL; VACCINATION;

FEMALE; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; RUBELLA; RUBELLA SYNDROME, CONGENITAL; RUBELLA VACCINE; VACCINATION;

EID: 84918536278     PISSN: 01973851     EISSN: 10970223     Source Type: Journal    
DOI: 10.1002/pd.4467     Document Type: Review

References (75)

1. Gregg NM. Congenital cataract following German measles in mother. Trans Ophthalmol Soc Aust 1944;3:35-46.
2. Frey TK. Molecular biology of rubella virus. Adv Virus Res 1994;44:69-160.
3. Chaye H, Chong P, Tripet B, et al. Localization of the virus neutralizing and hemagglutinin epitopes of E1 glycoprotein of rubella virus. Virology 1992;189:483-92.
4. Ho-Terry L, Terry GM, Cohen A, et al. Immunological characterisation of the rubella E 1 glycoprotein. Brief report. Arch Virol 1986;90:145-52.
5. Best JM, Thomson A, Nores JR, et al. Rubella virus strains show no major antigenic differences. Intervirology 1992;34:164-8.
6. Standardization of the nomenclature for genetic characteristics of wild-type rubella viruses. Wkly Epidemiol Rec 2005;80:126-32.
7. Rubella virus nomenclature update: 2013. Wkly Epidemiol Rec 2013;88:337-48.
8. Controlling rubella and preventing congenital rubella syndrome - global progress, 2009. Wkly Epidemiol Rec 2010;85:413-8.
9. Centers for Disease Control and Prevention (CDC). Elimination of rubella and congenital rubella syndrome - United States, 1969-2004. MMWR Morb Mortal Wkly Rep 2005;54:279-82.
10. Reef SE, Frey TK, Theall K, et al. The changing epidemiology of rubella in the 1990s: on the verge of elimination and new challenges for control and prevention. JAMA 2002;287:464-72.
11. Centers for Disease Control and Prevention (CDC). Three cases of congenital rubella syndrome in the postelimination era - Maryland, Alabama, and Illinois, 2012. MMWR Morb Mortal Wkly Rep 2013;62:226-9.
12. Division of Vaccines and Immunization. Final Report: Conclusions and Recommendations. 12th Meeting of the Technical Advisory Group on Vaccine Preventable Diseases. Guatemala, Washington, DC: Pan American Health Organization, 1997.
13. Dayan GH, Castillo-Solórzano C, Nava M, et al. Efforts at rubella elimination in the United States: the impact of hemispheric rubella control. Clin Infect Dis 2006; 43(Suppl 3):S158-63.
14. Strategic Plan for Measles and Congenital Rubella Infection in the European Region of WHO. Copenhagen: WHO Regional Office for Europe, 2003.
15. Measles and Rubella Monitoring Report. Stockholm: European Centre for Disease Prevention and Control (ECDC), 2013.
16. Annual Epidemiological Report on Communicable Diseases in Europe. Stockholm: European Centre for Disease Prevention and Control (ECDC), 2011.
17. Centers for Disease Control and Prevention (CDC). Progress toward measles control - African region, 2001-2008. MMWR Morb Mortal Wkly Rep 2009; 58:1036-41.
18. Guidelines for measles surveillance. Brazzaville, Republic of Congo: World Health Organization Regional Office for Africa, 2006.
19. Meeting Report: 20th Meeting of the TAG on Immunization and VPD in the Western Pacific Region. World Health Organization Western Pacific Region, 2011.
20. Davidkin I, Jokinen S, Broman M, et al. Persistence of measles, mumps, and rubella antibodies in an MMR-vaccinated cohort: a 20-year follow-up. J Infect Dis 2008;197:950-6.
21. Kremer JR, Schneider F, Muller CP. Waning antibodies in measles and rubella vaccinees - a longitudinal study. Vaccine 2006;24:2594-601.
22. LeBaron CW, Forghani B, Matter L, et al. Persistence of rubella antibodies after 2 doses of measles-mumps-rubella vaccine. J Infect Dis 2009;200:888-99.
23. O'Shea S, Woodward S, Best JM, et al. Rubella vaccination: persistence of antibodies for 10-21years. Lancet 1988;2:909.
24. McLean HQ, Fiebelkorn AP, Temte JL, et al. Prevention of measles, rubella, congenital rubella syndrome, and mumps, 2013: summary recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2013;62:1-34.
25. Institut de Veille Sanitaire. Le calendrier des vaccinations et recommandations vaccinales 2013 selon l'avis du Haut Conseil de Santé Publique. Bull Epidemiol Hebd 2013;14-15:131-58.
26. Demicheli V, Rivetti A, Debalini MG, et al. Vaccines for measles, mumps and rubella in children. Cochrane Database Syst Rev 2012;2:CD004407.
27. Tingle AJ, Mitchell LA, Grace M, et al. Randomised double-blind placebo-controlled study on adverse effects of rubella immunisation in seronegative women. Lancet 1997;349:1277-81.
28. Centers for Disease Control (CDC). Rubella vaccination during pregnancy - United States, 1971-1988. MMWR Morb Mortal Wkly Rep 1989;38:289-93.
29. Bar-Oz B, Levichek Z, Moretti ME, et al. Pregnancy outcome following rubella vaccination: a prospective controlled study. Am J Med Genet A 2004;130A:52-4.
30. Hamkar R, Jalilvand S, Abdolbaghi MH, et al. Inadvertent rubella vaccination of pregnant women: evaluation of possible transplacental infection with rubella vaccine. Vaccine 2006;24:3558-63.
31. Da Silva e Sá GR, Camacho LAB, Siqueira MM, et al. Seroepidemiological profile of pregnant women after inadvertent rubella vaccination in the state of Rio de Janeiro, Brazil, 2001-2002. Rev Panam Salud Publica 2006;19:371-8.
32. Minussi L, Mohrdieck R, Bercini M, et al. Prospective evaluation of pregnant women vaccinated against rubella in southern Brazil. Reprod Toxicol 2008;25:120-3.
33. Castillo-Solórzano C, Reef SE, Morice A, et al. Rubella vaccination of unknowingly pregnant women during mass campaigns for rubella and congenital rubella syndrome elimination, the Americas 2001-2008. J Infect Dis 2011;204(Suppl 2):S713-7.
34. Global Measles & Rubella Strategic Plan 2012-2020. Geneva: World Health Organization, 2012.
35. Anderson MJ, Kidd IM, Morgan-Capner P. Human parvovirus and rubella-like illness. Lancet 1985;2:663.
36. Bechar M, Davidovich S, Goldhammer G, et al. Neurological complications following rubella infection. J Neurol 1982;226:283-7.
37. Figueiredo CA, Klautau GB, Afonso AMS, et al. Isolation and genotype analysis of rubella virus from a case of Guillain-Barré syndrome. J Clin Virol 2008;43:343-5.
38. Best JM, Banatvala JE, Morgan-Capner P, et al. Fetal infection after maternal reinfection with rubella: criteria for defining reinfection. BMJ 1989;299:773-5.
39. HPA Rash Guidance Working Group. Guidance on Viral Rash in Pregnancy. Investigation, Diagnosis and Management of Viral Rash Illness or Exposure to Viral Rash Illness in Pregnancy. London: Health Protection Agency, 2011.
40. Bosma TJ, Best JM, Corbett KM, et al. Nucleotide sequence analysis of a major antigenic domain of the E1 glycoprotein of 22 rubella virus isolates. J Gen Virol 1996;77(Pt 10):2523-30.
41. Frey TK, Abernathy ES, Bosma TJ, et al. Molecular analysis of rubella virus epidemiology across three continents, North America, Europe, and Asia, 1961-1997. J Infect Dis 1998;178:642-50.
42. Infectious Diseases in Pregnancy Screening Programme. Programme Standards. UK National Screening Committee, 2010.
43. Recommandations en santé publique. Surveillance sérologique et prévention de la toxoplasmose et de la rubéole au cours de la grossesse. Haute Autorité de Santé, 2009.
44. Infectious Diseases in Pregnancy Screening Programme. Handbook for laboratories. UK National Screening Committee, 2012.
45. Cordier AG, Vauloup-Fellous C, Grangeot-Keros L, et al. Pitfalls in the diagnosis of congenital rubella syndrome in the first trimester of pregnancy. Prenat Diagn 2012;32:496-7.
46. Best JM, O'Shea S, Tipples G, et al. Interpretation of rubella serology in pregnancy - pitfalls and problems. BMJ 2002;325:147-8.
47. Best JM, Enders G. Chapter 3 Laboratory diagnosis of rubella and congenital rubella. Perspect Med Virol 2006;15:39-77.
48. Manual for the Laboratory Diagnosis of Measles and Rubella Virus Infection (2nd edn). Geneva: World Health Organization (WHO), 2007.
49. Vauloup-Fellous C, Grangeot-Keros L. Humoral immune response after primary rubella virus infection and after vaccination. Clin Vaccine Immunol 2007;14:644-7.
50. Grangeot-Keros L, Nicolas JC, Bricout F, et al. Rubella reinfection and the fetus. N Engl J Med 1985;313:1547.
51. Thomas HI, Barrett E, Hesketh LM, et al. Simultaneous IgM reactivity by EIA against more than one virus in measles, parvovirus B19 and rubella infection. J Clin Virol 1999;14:107-18.
52. Kurtz JB, Anderson MJ. Cross-reactions in rubella and parvovirus specific IgM tests. Lancet 1985;2:1356.
53. Grangeot-Keros L. L'avidité des IgG: implications en infectiologie. Immuno-Anal Biol Spéc 2001;16:87-91.
54. Mubareka S, Richards H, Gray M, et al. Evaluation of commercial rubella immunoglobulin G avidity assays. J Clin Microbiol 2007;45:231-3.
55. Vauloup-Fellous C, Ursulet-Diser J, Grangeot-Keros L. Development of a rapid and convenient method for determination of rubella virus-specific immunoglobulin G avidity. Clin Vaccine Immunol 2007;14:1416-9.
56. Vynnycky E, Admas E. Report on the global burden of rubella and congenital rubella syndrome, 2000-2008. Unpublished data.
57. Réseau Rénarub, Institut National de Veille Sanitaire. Données épidémiologies, 2011. URL http://www.invs.sante.fr/Dossiers-thematiques/Maladies-infectieuses/Maladies-a-prevention-vaccinale/Rubeole/Donnees-epidemiologiques [accessed on].
58. Lee JY, Bowden DS. Rubella virus replication and links to teratogenicity. Clin Microbiol Rev 2000;13:571-87.
59. Adamo MP, Zapata M, Frey TK. Analysis of gene expression in fetal and adult cells infected with rubella virus. Virology 2008;370:1-11.
60. Buimovici-Klein E, Lang PB, Ziring PR, et al. Impaired cell-mediated immune response in patients with congenital rubella: correlation with gestational age at time of infection. Pediatrics 1979;64:620-6.
61. Rabinowe SL, George KL, Loughlin R, et al. Congenital rubella. Monoclonal antibody-defined T cell abnormalities in young adults. Am J Med 1986;81:779-82.
62. Miller E, Cradock-Watson JE, Pollock TM. Consequences of confirmed maternal rubella at successive stages of pregnancy. Lancet 1982;2:781-4.
63. Enders G, Nickerl-Pacher U, Miller E, et al. Outcome of confirmed periconceptional maternal rubella. Lancet 1988;1:1445-7.
64. Cooper LZ, Alford CA Jr. Chapter 28 - rubella. In Infectious Diseases of the Fetus and Newborn Infant (6th edn). Philadelphia: W.B. Saunders, 2006;893-926.
65. Oster ME, Riehle-Colarusso T, Correa A. An update on cardiovascular malformations in congenital rubella syndrome. Birth Defects Res A Clin Mol Teratol 2010;88:1-8.
66. Givens KT, Lee DA, Jones T, et al. Congenital rubella syndrome: ophthalmic manifestations and associated systemic disorders. Br J Ophthalmol 1993;77:358-63.
67. Ginsberg-Fellner F, Witt ME, Fedun B, et al. Diabetes mellitus and autoimmunity in patients with the congenital rubella syndrome. Rev Infect Dis 1985;7(Suppl 1):S170-6.
68. Takasu N, Ikema T, Komiya I, et al. Forty-year observation of 280 Japanese patients with congenital rubella syndrome. Diabetes Care 2005;28:2331-2.
69. Forrest JM, Turnbull FM, Sholler GF, et al. Gregg's congenital rubella patients 60years later. Med J Aust 2002;177:664-7.
70. Clarke WL, Shaver KA, Bright GM, et al. Autoimmunity in congenital rubella syndrome. J Pediatr 1984;104:370-3.
71. Macé M, Cointe D, Six C, et al. Diagnostic value of reverse transcription-PCR of amniotic fluid for prenatal diagnosis of congenital rubella infection in pregnant women with confirmed primary rubella infection. J Clin Microbiol 2004;42:4818-20.
72. Thomas HIJ, Morgan-Capner P, Cradock-Watson JE, et al. Slow maturation of IgG1 avidity and persistence of specific IgM in congenital rubella: implications for diagnosis and immunopathology. J Med Virol 1993;41:196-200.
73. Bosma TJ, Corbett KM, Eckstein MB, et al. Use of PCR for prenatal and postnatal diagnosis of congenital rubella. J Clin Microbiol 1995;33:2881-7.
74. Callen P. Ultrasound in Obstetric and Gynaecology (4th edn). Philadelphia: Saunders Company, 2000.
75. Migliucci A, Di Fraja D, Sarno L, et al. Prenatal diagnosis of congenital rubella infection and ultrasonography: a preliminary study. Minerva Ginecol 2011;63:485-9.